430 related articles for article (PubMed ID: 18547188)
1. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation.
Tzikas TL
Dermatol Surg; 2008 Jun; 34 Suppl 1():S9-15. PubMed ID: 18547188
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face.
Sadick NS; Katz BE; Roy D
Dermatol Surg; 2007 Dec; 33 Suppl 2():S122-6; discussion S126-7. PubMed ID: 18086049
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation.
Jansen DA; Graivier MH
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):22S-30S, discussion 31S-33S. PubMed ID: 16936541
[TBL] [Abstract][Full Text] [Related]
4. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI.
Marmur ES; Taylor SC; Grimes PE; Boyd CM; Porter JP; Yoo JY
Dermatol Surg; 2009 Oct; 35 Suppl 2():1641-5. PubMed ID: 19708876
[TBL] [Abstract][Full Text] [Related]
5. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds.
Moers-Carpi M; Vogt S; Santos BM; Planas J; Vallve SR; Howell DJ
Dermatol Surg; 2007 Dec; 33 Suppl 2():S144-51. PubMed ID: 18086052
[TBL] [Abstract][Full Text] [Related]
6. Calcium hydroxylapatite versus nonanimal stabilized hyaluronic acid for the correction of nasolabial folds: a 12-month, multicenter, prospective, randomized, controlled, split-face trial.
Moers-Carpi MM; Tufet JO
Dermatol Surg; 2008 Feb; 34(2):210-5. PubMed ID: 18093199
[TBL] [Abstract][Full Text] [Related]
7. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds.
Smith S; Busso M; McClaren M; Bass LS
Dermatol Surg; 2007 Dec; 33 Suppl 2():S112-21; discussion S121. PubMed ID: 18086048
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus.
Carruthers A; Carruthers J
Dermatol Surg; 2008 Nov; 34(11):1486-99. PubMed ID: 18811715
[TBL] [Abstract][Full Text] [Related]
9. Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions.
Alam M; Yoo SS
J Am Acad Dermatol; 2007 Feb; 56(2):285-9. PubMed ID: 17224371
[TBL] [Abstract][Full Text] [Related]
10. A retrospective review of calcium hydroxylapatite for correction of volume loss in the infraorbital region.
Hevia O
Dermatol Surg; 2009 Oct; 35(10):1487-94. PubMed ID: 19614938
[TBL] [Abstract][Full Text] [Related]
11. Long-lasting results with hydroxylapatite (Radiesse) facial filler.
Jacovella PF; Peiretti CB; Cunille D; Salzamendi M; Schechtel SA
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):15S-21S. PubMed ID: 16936540
[TBL] [Abstract][Full Text] [Related]
12. Injectable calcium hydroxylapatite microspheres (Radiesse).
Ridenour B; Kontis TC
Facial Plast Surg; 2009 May; 25(2):100-5. PubMed ID: 19415577
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres.
Roy D; Sadick N; Mangat D
Dermatol Surg; 2006 Sep; 32(9):1134-9. PubMed ID: 16970693
[TBL] [Abstract][Full Text] [Related]
14. Calcium hydroxylapatite facial filler (Radiesse): indications, technique, and results.
Jacovella PF
Clin Plast Surg; 2006 Oct; 33(4):511-23. PubMed ID: 17085220
[TBL] [Abstract][Full Text] [Related]
15. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability.
Silvers SL; Eviatar JA; Echavez MI; Pappas AL
Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):34S-45S. PubMed ID: 16936543
[TBL] [Abstract][Full Text] [Related]
16. Controlled, randomized study of pain levels in subjects treated with calcium hydroxylapatite premixed with lidocaine for correction of nasolabial folds.
Marmur E; Green L; Busso M
Dermatol Surg; 2010 Mar; 36(3):309-15. PubMed ID: 20100272
[TBL] [Abstract][Full Text] [Related]
17. Calcium hydroxylapatite for facial rejuvenation.
Berlin A; Cohen JL; Goldberg DJ
Semin Cutan Med Surg; 2006 Sep; 25(3):132-7. PubMed ID: 17055392
[TBL] [Abstract][Full Text] [Related]
18. The role of calcium hydroxylapatite (Radiesse) in nonsurgical aesthetic rejuvenation.
Lizzul PF; Narurkar VA
J Drugs Dermatol; 2010 May; 9(5):446-50. PubMed ID: 20480786
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of injectable CaHA for the treatment of mid-face volume loss.
Beer K; Yohn M; Cohen JL
J Drugs Dermatol; 2008 Apr; 7(4):359-66. PubMed ID: 18459517
[TBL] [Abstract][Full Text] [Related]
20. Radiesse nodule of the lips from a distant injection site: report of a case and consideration of etiology and management.
Beer KR
J Drugs Dermatol; 2007 Aug; 6(8):846-7. PubMed ID: 17763619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
